Treeline Biosciences CSO Jeffrey Engelman (L) and CEO Josh Bilenker
Secretive Treeline Biosciences discloses $421M financing in filing
Josh Bilenker and Jeff Engelman’s secretive startup Treeline Biosciences has another $421 million, according to a new SEC
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.